Last reviewed · How we verify
KP001
At a glance
| Generic name | KP001 |
|---|---|
| Sponsor | Kokua Pharma Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome (PHASE3)
- A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of KP-001 (PHASE1)
- A Study to Evaluate the Effects of KP-001 on the QT/QTc Intervals in Healthy Adults (PHASE1)
- To Determine the Effect of KP-001 on Rosuvastatin, Caffeine PK and the Effect of Fluvoxamine on KP-001 PK in Volunteers (PHASE1)
- Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers (PHASE1)
- A Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KP001 CI brief — competitive landscape report
- KP001 updates RSS · CI watch RSS
- Kokua Pharma Inc. portfolio CI